Skip To Main Content
Shyna Gunalan on Muck Rack

Shyna Gunalan

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shyna

Contact Shyna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dynamic Risk Modelling of Hepatocellular Carcinoma

|
By Zhenning Yu, Shyna Gunalan, Ken Liu
| Wiley Online Library Verified
Disclosure Use of Generative AI: The authors used ChatGPT (OpenAI) for language editing and grammar refinement. The authors reviewed and edited the manuscript and take full responsibility for its content. Conflicts of Interest Mark Muthiah D has served as a consultant to Roche, Estella and Gilead. He has been an advisor for LernaBio. Mark Muthiah D has received payment from speaking at Boston Scientific, Olympus Medical, Roche and Astellas. He also serves as the CMO of LiverGENIX PTE LTD.
Open in Who Shared Issue with article?

Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance

|
By Benjamin Koh, Ryan Lim, Nicholas Syn, Shyna Gunalan
| Wiley Online Library Verified
Conflicts of Interest D.Q.H. receives funding support from the Singapore Ministry of Health's National Medical Research Council (MOH-000595-01 and MOH-001566) and the NUH Clinician Scientist Program (NCSP2.0/2023/NUHS/DH). C.H.N. and M.M. served as consultants for Boxer Capital. A.N. has received grant support from Ajinomoto Co. Inc., Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Mylan N.V., Otsuka Pharmaceutical Co. Ltd., Biofermin Seiyaku Co. Ltd. and Taisho Pharmaceutical Co. Ltd.
Open in Who Shared Issue with article?
See all 2 articles